Role of lipid peroxidation and oxidative stress in the association between thyroid diseases and breast cancer

Critical Reviews in Oncology/Hematology

Volumn 68, Issue 2, 2008, Pages 107-114

  Gago Dominguez, Manuela ^a,b   Castelao, Jose Esteban ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

Hyperthyroidism; Hypothyroidism; Iodine; Oxidative stress; Thyroid diseases

Indexed keywords

IODINE; IODINE 131; THYROID HORMONE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; BREAST CELL; CANCER RISK; CORRELATION ANALYSIS; CYTOTOXICITY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; HYPERTHYROIDISM; LIPID PEROXIDATION; LYMPHOCYTE; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK FACTOR; RISK REDUCTION; SIDE EFFECT; THYROID DISEASE; THYROID GLAND;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; RISK FACTORS; THYROID DISEASES;

EID: 52349108132     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.03.007     Document Type: Review

References (80)

1. Goldman M.B. Thyroid diseases and breast cancer. Epidemiol Rev 12 (1990) 16-28
2. Smyth P.P. The thyroid and breast cancer: a significant association?. Ann Med 29 (1997) 189-191
3. Smyth P.P., Smith D.F., McDermott E.W., Murray M.J., Geraghty J.G., and O'Higgins N.J. A direct relationship between thyroid enlargement and breast cancer. J Clin Endocrinol Metab 81 (1996) 937-941
4. Giani C., Fierabracci P., Bonacci R., Gigliotti A., Campani D., De Negri F., et al. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab 81 (1996) 990-994
5. Beatson G.T. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases. Lancet 2 2 (1896) 104-107
6. Beatson G.T. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 2 (1896) 162-165
7. Smyth P.P. The thyroid, iodine and breast cancer. Breast Cancer Res 5 (2003) 235-238
8. Kuijpens J.L., Nyklictek I., Louwman M.W., Weetman T.A., Pop V.J., and Coebergh J.W. Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15 (2005) 1253-1259
9. Turken O., NarIn Y., DemIrbas S., Onde M.E., Sayan O., KandemIr E.G., et al. Breast cancer in association with thyroid disorders. Breast Cancer Res (2003) 5
10. Bogardus G.M., and Finley J.W. Breast cancer and thyroid disease. Surgery 49 (1961) 461-468
11. Adamopoulos D.A., Vassilaros S., Kapolla N., Papadiamantis J., Georgiakodis F., and Michalakis A. Thyroid disease in patients with benign and malignant mastopathy. Cancer 57 (1986) 125-128
12. Shering S.G., Zbar A.P., Moriarty M., McDermott E.W., O'Higgins N.J., and Smyth P.P. Thyroid disorders and breast cancer. Eur J Cancer Prev 5 (1996) 504-506
13. Ron E., Curtis R., Hoffman D.A., and Flannery J.T. Multiple primary breast and thyroid cancer. Br J Cancer 49 (1984) 87-92
14. Dumont J.E., Maenhaut C., Pirson I., Baptist M., and Roger P.P. Growth factors controlling the thyroid gland. Baillieres Clin Endocrinol Metab 5 (1991) 727-754
15. Takatani O., Okumoto T., Kosano H., Nishida M., Hiraide H., and Tamakuma S. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res 49 (1989) 3109-3112
16. Gago-Dominguez M., Castelao J., Pike M.C., Sevanian A., and Haile R.W. Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 2829-2839
17. Gago-Dominguez M., Jiang X., and Castelao J. Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 9 (2006) 201-212
18. Gago-Dominguez M., Jiang X., and Castelao J. Lipid peroxidation and the protective effect of physical exercise on breast cancer. Med Hypotheses 68 (2007) 1138-1143
19. Asayama K., Dobashi K., Hayashibe H., Megata Y., and Kato K. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology 121 (1987) 2112-2118
20. Pereira B., Rosa L.F., Safi D.A., Bechara E.J., and Curi R. Control of superoxide dismutase, catalase and glutathione peroxidase activities in rat lymphoid organs by thyroid hormones. J Endocrinol 140 (1994) 73-77
21. Costantini F., Pierdomenico S.D., De Cesare D., De Remigis P., Bucciarelli T., Bittolo-Bon G., et al. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 18 (1998) 732-737
22. Swaroop A., and Ramasarma T. Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem J 226 (1985) 403-408
23. Paller M.S. Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidney Int 29 (1986) 1162-1166
24. Videla L.A., Sir T., and Wolff C. Increased lipid peroxidation in hyperthyroid patients: suppression by propylthiouracil treatment. Free Radic Res Commun 5 (1988) 1-10
25. Seven A., Tasan E., Hatemi H., and Burcak G. The impact of propylthiouracil therapy on lipid peroxidation and antioxidant status parameters in hyperthyroid patients. Acta Med Okayama 53 (1999) 27-30
26. Dirican M., and Tas S. Effects of vitamin E and vitamin C supplementation on plasma lipid peroxidation and on oxidation of apolipoprotein B-containing lipoproteins in experimental hyperthyroidism. J Med Invest 46 (1999) 29-33
27. Bianchi G., Solaroli E., Zaccheroni V., Grossi G., Bargossi A.M., Melchionda N., et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res 31 (1999) 620-624
28. Adali M., Inal-Erden M., Akalin A., and Efe B. Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin Biochem 32 (1999) 363-367
29. + ATPase activity in female hyperthyroid patients. J Toxicol Environ Health A 63 (2001) 289-295
30. Chehade J., Kim J., Pinnas J.L., and Mooradian A.D. Age-related changes in the thyroid hormone effects on malondialdehyde-modified proteins in the rat heart. Proc Soc Exp Biol Med 222 (1999) 59-64
31. Chehade J., Kim J., Pinnas J.L., and Mooradian A.D. Malondialdehyde binding of rat cerebral proteins is reduced in experimental hypothyroidism. Brain Res 829 (1999) 201-203
32. Fernandez V., and Videla L.A. Effect of hyperthyroidism on the biliary release of thiobarbituric acid reactants in the rat. Toxicol Lett 84 (1996) 149-153
33. Tapia G., Pepper I., Smok G., and Videla L.A. Kupffer cell function in thyroid hormone-induced liver oxidative stress in the rat. Free Radic Res 26 (1997) 267-279
34. Videla L.A., and Fernandez V. Thyroid calorigenesis and oxidative stress: modification of the respiratory burst activity in polymorphonuclear leukocytes. Braz J Med Biol Res 27 (1994) 2331-2342
35. Morini P., Casalino E., Sblano C., and Landriscina C. The response of rat liver lipid peroxidation, antioxidant enzyme activities and glutathione concentration to the thyroid hormone. Int J Biochem 23 (1991) 1025-1030
36. Asayama K., Dobashi K., Hayashibe H., and Kato K. Vitamin E protects against thyroxine-induced acceleration of lipid peroxidation in cardiac and skeletal muscles in rats. J Nutr Sci Vitaminol (Tokyo) 35 (1989) 407-418
37. Kose K., Terzi S., and Dogan P. The relationship between high plasma thyroid hormone (T4, T3) levels and oxidative damage. Ann Med Sci 6 (1997) 102-106
38. Bech K., Damsbo P., Eldrup E., Beck-Nielsen H., Roder M.E., Hartling S.G., et al. Beta-cell function and glucose and lipid oxidation in Graves' disease. Clin Endocrinol (Oxf) 44 (1996) 59-66
39. Salganik R.I. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20 (2001) 473S-475S
40. Jacobson M.D. Reactive oxygen species and programmed cell death. Trends Biochem Sci 21 (1996) 83-86
41. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
42. Buttke T.M., and Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol Today 15 (1994) 7-10
43. Wikipedia contributors. Iodine [Internet]. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/w/index.php?title=Iodine&oldid=129097158 (accessed May 7, 2007).
44. Kimball JW. Reactive Oxygen Species (ROS) [Internet]. Kimball's Biology Pages. http://home.comcast.net/%7Ejohn.kimball1/BiologyPages/R/ROS.html, last updated July 15, 2006 (accessed May 7, 2007).
45. Taurog A. Hormone synthesis: thyroid iodine metabolism. In: Braverman L. U.R. (Ed). Werner and Ingbar's the thyroid (1996), Lippincott Co., Philadelphia 47?1
46. Shah N.M., Eskin B.A., Krouse T.B., and Sparks C.E. Iodoprotein formation by rat mammary glands during pregnancy and early postpartum period. Proc Soc Exp Biol Med 181 (1986) 443-449
47. Venturi S. Is there a role for iodine in breast diseases?. Breast 10 (2001) 379?82
48. -) treatment. Evidence that I2 prevents cancer promotion. Mol Cell Endocrinol 236 (2005) 49-57
49. Shrivastava A., Tiwari M., Sinha R.A., Kumar A., Balapure A.K., Bajpai V.K., et al. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281 (2006) 19762-19771
50. Brownstein D. Iodine: why you need it, why you can't live without it. Iodine: the anti-cancer agent (2006), Medical Alternatives Press, West Bloomfield, MI 48323, USA
51. Denef J.F., Many M.C., and van den Hove M.F. Iodine-induced thyroid inhibition and cell necrosis: two consequences of the same free-radical mediated mechanism?. Mol Cell Endocrinol 121 (1996) 101-103
52. Vitale M., Di Matola T., D'Ascoli F., Salzano S., Bogazzi F., Fenzi G., et al. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 141 (2000) 598-605
53. Arroyo-Helguera O., Anguiano B., Delgado G., and Aceves C. Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line. Endocr Relat Cancer 13 (2006) 1147-1158
54. Wikipedia contributors. Oxidizing agent [Internet]. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/w/index.php?title=Oxidizing_agent&oldid=1278 90598 (accessed May 07, 2007).
55. Organic Chemistry Portal. Iodine [Internet]. http://www.organic-chemistry.org/chemicals/oxidations/iodine.shtm (accessed May 7, 2007).
56. Smyth P.P. Role of iodine in antioxidant defence in thyroid and breast disease. Biofactors 19 (2003) 121-130
57. Zhang L., Sharma S., Zhu L.X., Kogai T., Hershman J.M., Brent G.A., et al. Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. Cancer Res 63 (2003) 5065-5072
58. Strum J.M. Site of iodination in rat mammary gland. Anat Rec 192 (1978) 235-244
59. Boeynaems J.M., and Hubbard W.C. Transformation of arachidonic acid into an iodolactone by the rat thyroid. J Biol Chem 255 (1980) 9001-9004
60. Turk J., Henderson W.R., Klebanoff S.J., and Hubbard W.C. Iodination of arachidonic acid mediated by eosinophil peroxidase, myeloperoxidase and lactoperoxidase. Identification and comparison of products. Biochim Biophys Acta 751 (1983) 189-200
61. Ekholm R., and Bjorkman U. Glutathione peroxidase degrades intracellular hydrogen peroxide and thereby inhibits intracellular protein iodination in thyroid epithelium. Endocrinology 138 (1997) 2871-2878
62. Aceves C., Anguiano B., and Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland?. J Mammary Gland Biol Neoplasia 10 (2005) 189-196
63. Dugrillon A., Bechtner G., Uedelhoven W.M., Weber P.C., and Gartner R. Evidence that an iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′,5′-monophosphate formation. Endocrinology 127 (1990) 337-343
64. Pisarev M.A., Krawiec L., Juvenal G.J., Bocanera L.V., Pregliasco L.B., Sartorio G., et al. Studies on the goiter inhibiting action of iodolactones. Eur J Pharmacol 258 (1994) 33-37
65. Langer R., Burzler C., Bechtner G., and Gartner R. Influence of iodide and iodolactones on thyroid apoptosis. Evidence that apoptosis induced by iodide is mediated by iodolactones in intact porcine thyroid follicles. Exp Clin Endocrinol Diab 111 (2003) 325-329
66. Mutaku J.F., Poma J.F., Many M.C., Denef J.F., and van Den Hove M.F. Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. J Endocrinol 172 (2002) 375-386
67. Mihara S., Suzuki N., Wakisaka S., Suzuki S., Sekita N., Yamamoto S., et al. Effects of thyroid hormones on apoptotic cell death of human lymphocytes. J Clin Endocrinol Metab 84 (1999) 1378-1385
68. Rees Smith B., McLachlan S.M., and Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 9 (1988) 106-121
69. Ansell J. The blood in thyrotoxicosis. Werner and Ingbar the thyroid (1996), Lippincott-Raven, Philadelphia
70. Grinblat J., Shohat B., Lewitus Z., and Joshua H. Quantitative and functional assessment of peripheral T-lymphocytes in thyroid diseases. Acta Endocrinol (Copenh) 90 (1979) 52-61
71. Wall J.R., Gray B., and Greenwoood D.M. Total and "activated" peripheral blood T lymphocytes in patients with thyroid disorders. Acta Endocrinol (Copenh) 85 (1977) 753-759
72. Funahashi H., Imai T., Tanaka Y., Tsukamura K., Hayakawa Y., Kikumori T., et al. Wakame seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats. Jpn J Cancer Res 90 (1999) 922-927
73. Kato N., Funahashi H., Ando K., and Takagi H. Suppressive effect of iodine preparations on proliferation of DMBA-induced breast cancer in rat. J Jpn Soc Cancer Ther 29 (1994) 582-588
74. Varas S.M., Munoz E.M., Hapon M.B., Aguilera Merlo C.I., Gimenez M.S., and Jahn G.A. Hyperthyroidism and production of precocious involution in the mammary glands of lactating rats. Reproduction 124 (2002) 691-702
75. Gonzalez-Sancho J.M., Figueroa A., Lopez-Barahona M., Lopez E., Beug H., and Munoz A. Inhibition of proliferation and expression of T1 and cyclin D1 genes by thyroid hormone in mammary epithelial cells. Mol Carcinog 34 (2002) 25-34
76. Jorns A., Tiedge M., and Lenzen S. Thyroxine induces pancreatic beta cell apoptosis in rats. Diabetologia 45 (2002) 851-855
77. Pasquini L.A., Marta C.B., Adamo A.M., Pasquini J.M., and Soto E.F. Relationship between the ubiquitin-dependent pathway and apoptosis in different cells of the central nervous system: effect of thyroid hormones. Neurochem Res 25 (2000) 627-635
78. Huang X.W., Zhao Z.Y., and Ji C. Effects of hypothyroidism on apoptosis and the expression of Bcl-2 and Bax gene in the neonatal rat hippocampus neurons. Zhonghua Er Ke Za Zhi 43 (2005) 48-52
79. Chen A.Y., Levy L., Goepfert H., Brown B.W., Spitz M.R., and Vassilopoulou-Sellin R. The development of breast carcinoma in women with thyroid carcinoma. Cancer 92 (2001) 225-231
80. Mannello F., Tonti G.A., Pagliarani S., Benedetti S., Canestrari F., Zhu W., et al. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer 120 (2007) 1971-1976